Copyright
        ©The Author(s) 2004.
    
    
        World J Gastroenterol. Oct 1, 2004; 10(19): 2795-2799
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2795
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2795
            Table 1 Relationship between the HPA expression and the clinicopathological parameters of HCC
        
    | Items | Number | HPA positive | HPA negative | P value | 
| Size of tumor | ||||
| > 5 cm | 25 | 13 | 12 | 0.250 | 
| ≤ 5 cm | 8 | 3 | 5 | |
| Tumor capsule | ||||
| Integrated | 14 | 5 | 9 | 0.130 | 
| Disintegrated | 19 | 11 | 8 | |
| AFP | ||||
| Positive | 21 | 12 | 9 | 0.125 | 
| Negative | 12 | 4 | 8 | |
| HBsAg | ||||
| Positive | 24 | 12 | 12 | 0.292 | 
| Negative | 9 | 4 | 5 | |
| Liver cirrhosis | ||||
| Yes | 18 | 8 | 10 | 0.241 | 
| No | 15 | 8 | 7 | |
| Edmondson grade | ||||
| I, II | 13 | 3 | 10 | 0.019 | 
| III, IV | 20 | 13 | 7 | |
| TNM staging | ||||
| I, II | 18 | 6 | 12 | 0.047 | 
| III, IV | 15 | 10 | 5 | 
            Table 2 Relationship between HPA expression and metastatic recurrence of HCC
        
    | Items | Number | HPA positive | HPA negative | P value | 
| Tendency to metastatic recurrence | ||||
| High | 14 | 10 | 4 | 0.023 | 
| Low | 19 | 6 | 13 | |
| Metastatic recurrence | ||||
| Yes | 14 | 11 | 3 | 0.003 | 
| No | 14 | 3 | 11 | 
            Table 3 Sequencing and corresponding series number
        
    | Number | Nucleotide sequence | Remarks | |||||
| TTGG | GCCCGACGTC | GCATGCTCCC | GGCCGCCATG | GCGGCCGCGG | GAATTCGATT | Plasmid DNA | |
| 409-468 | TTCGATCCCA | AGAAGGAATC | AA1CCTTTGAA | GAGAGAAGTT | ACTGGCAATC | TCAAGTCAAC | HPA cDNA | 
| 469-528 | CAGGATATTT | GCAAATATGG | ATCCATCCCT | CCTGATGTGG | AGGAA3,5AAGTT | ACGGTTGGAA | HPA cDNA | 
| 529-588 | TGGCCCTACC | AGGAGCAATT | GCTACTCCGA | GAACACTACC | AGAAAAAGTT | CAAGAACAGC | HPA cDNA | 
| 589-648 | ACCTACTCAA | GAAGCTCTGT | AGATGTGCTA | TACACTTTTG | CAAACTGCTC | AGGACTGGAC | HPA cDNA | 
| 649-708 | TTGATCTTTG | GCCTAAATGC | GTTATTAAGA | ACAGCAGATT | TGCAGTGGAA | CAGTTCTAAT | HPA cDNA | 
| 709-768 | GCTCAGTTGC | TCCTGGACTA | CTGCTCTTCC | AAGGGGTATA | ACATTTCTTG | GGAACTAGGC | HPA cDNA | 
| 769-828 | AATGAACCTA | ACAGTTTCCT | TAAGAAGGCT | GATATTTTCA | TCAATGGGTC | GCAGTTAGGA | HPA cDNA | 
| 829-888 | GAAGATTTTA | TTCAATTGCA | TAAACTTCTA | AGAAAGTCCA | CCTTCAAAAG4 | T6GCAAAACTC | HPA cDNA | 
| 889-948 | TATGGTCCTG | ATGTTGGTCA | GCCTCGAAGA | AAGACGGCTA | AGATGCTGAA | GAGCTTCCTG | HPA cDNA | 
| 949-993 | AAGGCTGGTG | GAGAAGTGAT | TGATTCAGTT | ACATGGCATC | ACTAC2 | HPA cDNA | |
| AATCACTAGT | GAATTCGCGG | CCGCCTGCAG | GTCGACCATA | TGGGAGAGCT | CCCAACGCGT | Plasmid DNA | |
| TGAATCACTA | GTGAATTCGC | GGCCGCCTGC | AGGTCGACCA | TATGGGAGAG | CTCCCAACGC | Plasmid DNA | |
| GTTG | Plasmid DNA | ||||||
- Citation: Chen XP, Liu YB, Rui J, Peng SY, Peng CH, Zhou ZY, Shi LH, Shen HW, Xu B. Heparanase mRNA expression and point mutation in hepatocellular carcinoma. World J Gastroenterol 2004; 10(19): 2795-2799
- URL: https://www.wjgnet.com/1007-9327/full/v10/i19/2795.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i19.2795

 
         
                         
                 
                 
                 
                 
         
                         
                         
                        